Ticker LaunchRegulation A · Tier 2 · TTRX
Turn Therapeutics Inc.
Turn Therapeutics Inc. (TTRX) filed a Tier 2 Regulation A offering statement (Form 1-A) on Jan 31, 2025 for up to $18.1M at $11.26 per security. The SEC qualified the offering on Mar 31, 2025. Underwriter or broker: S, t and a.
- Status
- Qualified
- Tier
- Tier 2
- Offering size
- $18.1M
- Offer price
- $11.26
- Security type
- Equity (common or preferred stock)
- Filed
- Jan 31, 2025
- Qualified
- Mar 31, 2025
- Ticker
- TTRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- State
- CA
- Underwriter / broker
- S, t, a, r, E, n, g, i, e, P, m, y, L and C
More on this offering for subscribers
- Revenue, net income and total assets from the offering statement
- Employees
- Market cap at the offer price
- Auditor
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- Offering statement (Form 1-A) Jan 31, 2025
- Final offering circular (253G2)
- All filings on EDGAR CIK 2023016
Other qualified Biotech & pharma Reg A offerings
- Aibotics, Inc.Jul 1, 2025 · $5M
- Bio-Path Holdings, Inc.May 29, 2025 · $5M
- Cytonics CorpMar 14, 2025 · $24M
- Medicus Pharma Ltd.Mar 6, 2025 · $12.2M
- Nok Therapeutics, Inc.Jan 3, 2025 · $10M
- Jabez Biosciences, Inc.Dec 20, 2024 · $10M